NSE · MEDANTA · Healthcare
Global Health Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹44,10,26,60,000 Cr with net profit ₹5,56,46,00,000 Cr — a 12.62% net margin, versus 12.92% the period before.
Shareholding
As of 2026-06-30
- Promoter33%
- Public40.65%
- FII9.46%
- DII16.89%
1,40,531 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.52× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #6 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,472 Cr | 242.67 | 13.55 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,166 Cr | 315.74 | 10.07 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,876 Cr | 270.47 | 7.26 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,315 Cr | 187.89 | 9.34 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,227 Cr | 299.63 | 9.23 | 8.48% | 8.36% |
| Global Health Limited(this company) | ₹38,526 Cr | 267.33 | 9.72 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,517 Cr | 135.03 | 8.94 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,558 Cr | 239.5 | 12.58 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹17,015 Cr | 256.67 | 5.47 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,494 Cr | 391.04 | 7.65 | 6.58% | 6.4% |
AI analysis
AI-generated · google/gemini-2.5-flashGlobal Health Limited, operating under the symbol MEDANTA, has a market capitalization of Rs 35798 Cr. The company reported a revenue of Rs 4410.27 Cr with a profit margin of 12.62%. Its earnings per share (EPS) stands at Rs 20.73, and the stock is trading at a PE ratio of 248.4.
Positives
- +The company's revenue grew by 12.7%, indicating business expansion.
- +The debt-to-equity ratio is 0.24, suggesting a manageable debt level.
- +Promoter holding of 32.9992% is not pledged.
Negatives
- −The company's PE ratio is 248.4, which is high.
- −The promoter holding decreased from 33.0739% in June 2023 to 32.9992% in June 2026.
- −No quarterly results have been disclosed since March 2026.
Financial Performance
Global Health Limited recorded a revenue of Rs 4410.27 Cr, demonstrating a revenue growth of 12.7%. The net profit for the annual period ending March 2026 was Rs 556.46 Cr. For the quarter ending March 2026, the company's revenue was Rs 1159.05 Cr, with a net profit of Rs 143.99 Cr.
Profitability & Returns
The company’s profit margin is 12.62%. Return on equity (ROE) is 14.05%, and return on capital employed (ROCE) is 15.26%. The basic earnings per share (EPS) is Rs 20.73.
Balance Sheet
Global Health Limited has a book value per share of Rs 147.34. The debt-to-equity ratio is 0.24, indicating a modest level of debt relative to equity. The company does not currently offer a dividend, with a dividend yield of 0%.
Ownership & Pledges
Public shareholding stands at 40.6496%. There are no promoter shares pledged.
Regulatory & Surveillance
The company is not currently under any regulatory surveillance actions.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.